This study investigates the event-free survival of patients with intermediate-risk rhabdomyosarcoma (IR RMS), a type of cancer that forms in soft tissue, treated with different combinations of surgery, radiotherapy, and chemotherapy. The study compares two treatment arms: one involving surgery, radiotherapy, and a chemotherapy regimen called VAC/VI, and the other …